252 related articles for article (PubMed ID: 24777812)
1. Computational identification of pathogenic associated nsSNPs and its structural impact in UROD gene: a molecular dynamics approach.
Doss CG; Magesh R
Cell Biochem Biophys; 2014 Nov; 70(2):735-46. PubMed ID: 24777812
[TBL] [Abstract][Full Text] [Related]
2. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
[TBL] [Abstract][Full Text] [Related]
3. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
[TBL] [Abstract][Full Text] [Related]
4. Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT.
Christiansen L; Ged C; Hombrados I; Brons-Poulsen J; Fontanellas A; de Verneuil H; Hørder M; Petersen NE
Hum Mutat; 1999; 14(3):222-32. PubMed ID: 10477430
[TBL] [Abstract][Full Text] [Related]
5. Identification of a mutation in the ovine uroporphyrinogen decarboxylase (UROD) gene associated with a type of porphyria.
Nezamzadeh R; Seubert A; Pohlenz J; Brenig B
Anim Genet; 2005 Aug; 36(4):297-302. PubMed ID: 16026339
[TBL] [Abstract][Full Text] [Related]
6. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
[TBL] [Abstract][Full Text] [Related]
7. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
Doss CG; Nagasundaram N
Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
[TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: characterization of four novel mutations.
Méndez M; Rossetti MV; Gómez-Abecia S; Morán-Jiménez MJ; Parera V; Batlle A; Enríquez de Salamanca R
Mol Genet Metab; 2012 Apr; 105(4):629-33. PubMed ID: 22382040
[TBL] [Abstract][Full Text] [Related]
10. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M
Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314
[TBL] [Abstract][Full Text] [Related]
11. Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria.
Meguro K; Fujita H; Ishida N; Akagi R; Kurihara T; Galbraith RA; Kappas A; Zabriskie JB; Toback AC; Harber LC
J Invest Dermatol; 1994 May; 102(5):681-5. PubMed ID: 8176248
[TBL] [Abstract][Full Text] [Related]
12. Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria.
McManus JF; Begley CG; Sassa S; Ratnaike S
Blood; 1996 Nov; 88(9):3589-600. PubMed ID: 8896428
[TBL] [Abstract][Full Text] [Related]
13. Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus.
Ged C; Ozalla D; Herrero C; Lecha M; Mendez M; de Verneuil H; Mascaro JM
Arch Dermatol; 2002 Jul; 138(7):957-60. PubMed ID: 12071824
[TBL] [Abstract][Full Text] [Related]
14. Prediction of functionally significant single nucleotide polymorphisms in PTEN tumor suppressor gene: An in silico approach.
Khan I; Ansari IA; Singh P; Dass J FP
Biotechnol Appl Biochem; 2017 Sep; 64(5):657-666. PubMed ID: 26800850
[TBL] [Abstract][Full Text] [Related]
15. Impacts of Nonsynonymous Single Nucleotide Polymorphisms of Adiponectin Receptor 1 Gene on Corresponding Protein Stability: A Computational Approach.
Saleh MA; Solayman M; Paul S; Saha M; Khalil MI; Gan SH
Biomed Res Int; 2016; 2016():9142190. PubMed ID: 27294143
[TBL] [Abstract][Full Text] [Related]
16. Human gene mutations. Gene symbol: UROD. Disease: Porphyria, cutanea tarda.
Martinez di Montemuros F; Tavazzi D; Patti E; Cappellini MD
Hum Genet; 2004 Jan; 114(2):221. PubMed ID: 15046048
[No Abstract] [Full Text] [Related]
17. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis.
Shinwari K; Guojun L; Deryabina SS; Bolkov MA; Tuzankina IA; Chereshnev VA
ScientificWorldJournal; 2021; 2021():6642626. PubMed ID: 34234628
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations.
Christiansen L; Brøns-Poulsen J; Hørder M; Brock A; Petersen NE
Scand J Clin Lab Invest; 2005; 65(3):227-35. PubMed ID: 16095052
[TBL] [Abstract][Full Text] [Related]
20. Gene symbol: UROD. Disease: Porphyria, cutanea tarda.
Martinez di Montemuros F; Tavazzi D; Patti E; Cappellini MD
Hum Genet; 2003 Sep; 113(4):368. PubMed ID: 12974281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
